Api Details

Metformin Hydrochloride is a crucial pharmaceutical API utilized in the management of type 2 diabetes mellitus. It belongs to the class of biguanide drugs, which work by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues, thereby lowering blood sugar levels. This helps to improve glycemic control and reduce the risk of complications associated with diabetes. Administered orally, typically in tablet form, dosages vary based on individual patient needs and response. While generally well-tolerated, potential side effects may include gastrointestinal discomfort and lactic acidosis. Regulatory adherence ensures stringent quality and safety standards during manufacturing, ensuring reliability in Metformin Hydrochloride-containing pharmaceutical products.